Karam I Turk-Adawi1, Sherry L Grace2. 1. School of Health Policy and Management, York University, Toronto, Ontario, Canada; College of Health Professions, Al-Quds University, Jerusalem, Palestinian Authority. Electronic address: karamturk2000@yahoo.com. 2. School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada; Cardiovascular Rehabilitation & Prevention, University Health Network, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Cardiovascular disease is a leading cause of morbidity worldwide. Cardiac rehabilitation (CR) is a comprehensive secondary prevention approach, with established benefits in reducing morbidity in high-income countries (HICs). The objectives of this review were to summarise what is known about the benefits of CR, including consideration of cost-effectiveness, in addition to rates of CR participation and adherence in high-, as well as low- and middle-income countries (LMICs). METHODS: A literature search of Medline, Excerpta Medica Database (EMBASE), and Google Scholar was conducted for published articles from database inception to October 2013. The search was first directed to identify meta-analyses and reviews reporting on the benefits of CR. Then, the search was focussed to identify articles reporting CR participation and dropout rates. Full-text versions of relevant abstracts were summarised qualitatively. RESULTS: Based on meta-analysis, CR significantly reduced all-cause mortality by 13%-26%, cardiac mortality by 20%-36%, myocardial re-infarction by 25%-47%, and risk factors. CR is cost-effective in HICs. In LMICs, CR is demonstrated to reduce risk factors, with no studies on mortality or cost-effectiveness. Based on available data, CR participation rates are <50% in the majority of countries, with documented dropout rates up to 56% and 82% in high- and middle-income countries, respectively. CONCLUSIONS: CR is a beneficial intervention for heart patients in high and LMICs, but is underutilised with low participation and adherence rates worldwide. While more research is needed in LMICs, strategies shown to increase participation and program adherence should be implemented.
BACKGROUND:Cardiovascular disease is a leading cause of morbidity worldwide. Cardiac rehabilitation (CR) is a comprehensive secondary prevention approach, with established benefits in reducing morbidity in high-income countries (HICs). The objectives of this review were to summarise what is known about the benefits of CR, including consideration of cost-effectiveness, in addition to rates of CR participation and adherence in high-, as well as low- and middle-income countries (LMICs). METHODS: A literature search of Medline, Excerpta Medica Database (EMBASE), and Google Scholar was conducted for published articles from database inception to October 2013. The search was first directed to identify meta-analyses and reviews reporting on the benefits of CR. Then, the search was focussed to identify articles reporting CR participation and dropout rates. Full-text versions of relevant abstracts were summarised qualitatively. RESULTS: Based on meta-analysis, CR significantly reduced all-cause mortality by 13%-26%, cardiac mortality by 20%-36%, myocardial re-infarction by 25%-47%, and risk factors. CR is cost-effective in HICs. In LMICs, CR is demonstrated to reduce risk factors, with no studies on mortality or cost-effectiveness. Based on available data, CR participation rates are <50% in the majority of countries, with documented dropout rates up to 56% and 82% in high- and middle-income countries, respectively. CONCLUSIONS: CR is a beneficial intervention for heart patients in high and LMICs, but is underutilised with low participation and adherence rates worldwide. While more research is needed in LMICs, strategies shown to increase participation and program adherence should be implemented.
Authors: G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens Journal: Circulation Date: 1989-08 Impact factor: 29.690
Authors: Jose A Suaya; Donald S Shepard; Sharon-Lise T Normand; Philip A Ades; Jeffrey Prottas; William B Stason Journal: Circulation Date: 2007-09-24 Impact factor: 29.690
Authors: Alison Beauchamp; Marian Worcester; Andrew Ng; Barbara Murphy; James Tatoulis; Leeanne Grigg; Robert Newman; Alan Goble Journal: Heart Date: 2012-12-04 Impact factor: 5.994
Authors: Abraham Samuel Babu; Francisco Lopez-Jimenez; Randal J Thomas; Wanrudee Isaranuwatchai; Artur Haddad Herdy; Jeffrey S Hoch; Sherry L Grace Journal: BMC Health Serv Res Date: 2016-09-06 Impact factor: 2.655
Authors: Carolina Santiago de Araújo Pio; Gabriela Ss Chaves; Philippa Davies; Rod S Taylor; Sherry L Grace Journal: Cochrane Database Syst Rev Date: 2019-02-01
Authors: Amir Vahedian-Azimi; Andrew C Miller; Mohammadreza Hajiesmaieli; Mari Kangasniemi; Fatemah Alhani; Hosseinali Jelvehmoghaddam; Mohammad Fathi; Behrooz Farzanegan; Seyed H Ardehali; Sevak Hatamian; Mehdi Gahremani; Seyed M M Mosavinasab; Zohreh Rostami; Seyed J Madani; Morteza Izadi Journal: Open Heart Date: 2016-04-19
Authors: Leila Pfaeffli Dale; Robyn Whittaker; Yannan Jiang; Ralph Stewart; Anna Rolleston; Ralph Maddison Journal: J Med Internet Res Date: 2015-10-21 Impact factor: 5.428